TPP1 and cancer: Potential consequences for new treatments of hypoxia‐dependent diseases such as cancer [14], diabetes, heart‐related pathologies [18, 19, 20, 21], and respiratory distress, as seen in virus induced hypoxia as Coronavirus Disease 2019 (COVID‐19) [22] require an understanding of the molecular mechanisms by which ITPP enters RBCs and modifies the biochemical pathways of efficient O2 release [9].